G2G Consulting Maximizes Government Opportunities for Entrepreneurial Growth

Share on Social Media

RI Bio has partnered with non-dilutive funding and government affairs experts, G2G to provide support and monthly reports on non-dilutive financing and government funding for entrepreneurs and researchers running startups in Rhode Island. G2G was founded by Liz Powell, an entrepreneur and attorney with over 20 years of experience in government affairs. Previously, she served as the Legislative Director for two Members of Congress and staffing the Armed Services Committee and the Small Business Committee in Washington, D.C. Since 2007, G2G has secured over $211 million in government funding and has increased CMS reimbursement rates, led government marketing and advocacy campaigns, and implemented legislative and regulatory changes. G2G publishes the monthly GBG Report listing bioscience grants that is posted on their website.

By becoming a RI Bio member you will have free access to G2G’s monthly Government Bioscience Grants (GBG) Report. Click here to access a sample monthly report. To become a member, contact Carol Malysz at [email protected] 

Other great free resources from G2G:

  • Access G2G’s full Summary Report of the Military Health System Research Symposium by clicking here.
  • Find G2G Legislative Updates and Upcoming Events on their website by clicking here.

Stay tuned….we’ll be inviting G2G to Rhode Island for an in-person session in Spring 2020.

Latest News

HPNE Launches Initiative to Hire 150+ Employees by Q1 of 2022

HPNE Launches Initiative to Hire 150+ Employees by Q1 of 2022

Smithfield, RI – High Purity New England, a supplier of solutions and equipment for the biopharmaceutical industry, is undergoing a substantial hiring push – looking to immediately begin hiring more than 150+ employees by Q1 2022. Over the past few years alone,...

Amgen Releases 8th Edition of Biosimilar Trends Report

Amgen Releases 8th Edition of Biosimilar Trends Report

Report Finds That Competition Created by Biosimilars Delivered $9.8 Billion in Savings Over the Past Five Years to the U.S. Healthcare System, Generating Savings for Patients, Payers and EmployersWith Both a Strong Innovator Portfolio and a Deep Investment in...

Biotech Industry News